Camarões: Aposta vencedora na piscicultura melhora as condições de vida das populações

Source: Africa Press Organisation – Portuguese –

Nas regiões do Litoral e do Sudoeste dos Camarões, os viveiros piscícolas já não são apenas locais de produção, mas verdadeiros polos de oportunidade e transformação económica. Graças ao Projeto de Desenvolvimento das Cadeias de Valor da Pecuária e da Piscicultura (PD-CVEP) (https://apo-opa.co/4ngcBNG), financiado em 84 milhões de euros pelo Banco Africano de Desenvolvimento e implementado pelo Ministério da Pecuária, Pescas e Indústrias Animais dos Camarões, uma nova dinâmica traz esperança aos piscicultores, especialmente aos jovens e às mulheres.

No centro desta transformação está a distribuição de 2.600 reprodutores de uma variedade de peixes-gato africanos com elevado potencial, alta taxa de crescimento, baixo teor de gordura e baixa taxa de mortalidade, produzidos pelo Instituto de Investigação Agrícola para o Desenvolvimento. Estes reprodutores apresentam um desempenho significativamente melhorado: atingem o tamanho comercializável, ou seja, 350 a 500 gramas em 5 a 6 meses, contra 8 a 9 meses anteriormente, e apresentam uma taxa de sobrevivência dos alevins de 80 a 85%, contra cerca de 60% para as antigas estirpes. Cada fêmea pode produzir 15 mil a 20 mil alevins por ciclo, com até três ciclos por ano. No total, 50 incubadoras foram selecionadas para a fase de pré-divulgação. O projeto permite melhorar a qualidade genética dos peixes produzidos, reforçar a autonomia dos criadores e responder ao desafio nacional da segurança alimentar.

Desde outubro de 2024, estes reprodutores distribuídos em 50 incubadoras-piloto permitiram produzir e colocar à venda mais de 115 mil alevins, destinados principalmente ao crescimento. Embora esta operação ainda esteja em fase de pré-divulgação, os primeiros resultados são muito encorajadores. A maioria dos viveiros beneficiários relatou um desempenho satisfatório. Alguns reprodutores, ainda imaturos quando recebidos, necessitaram de um período de engorda de cerca de três meses, o que foi integrado no planeamento da produção.

“O apoio do projeto incentiva-nos a ir mais longe. É uma verdadeira motivação para continuar o que começámos. Agradecemos a todos os parceiros que tornaram este avanço possível. Hoje, sinto-me mais bem equipada para tornar a piscicultura uma atividade rentável”, disse Fanta Njifondjou Oumarou, piscicultora em Limbé, cidade costeira no noroeste dos Camarões.

Mas o projeto vai muito além do simples fornecimento de reprodutores. Ele faz parte de uma visão integrada de desenvolvimento do setor piscícola. Assim, 280 piscicultores de diferentes regiões dos Camarões beneficiaram de uma formação completa sobre todos os elos da cadeia: criação em gaiolas flutuantes, reprodução, gestão de incubadoras, alimentação aquícola e gestão empresarial. Esta abordagem visa reforçar as capacidades técnicas dos intervenientes, a sua resiliência económica e a qualidade dos produtos oferecidos no mercado local.

O Projeto de Desenvolvimento das Cadeias de Valor da Pecuária e da Piscicultura tem um objetivo estratégico: aumentar em 10 000 toneladas a produção nacional anual de peixe até 2027, a fim de reduzir a dependência das importações e melhorar a segurança alimentar. Para alcançar esta ambição, uma missão do Banco Africano de Desenvolvimento realizada em abril de 2025 recomendou a aceleração da importação de reprodutores melhorados de clarias e tilápias, a fim de enriquecer a base genética nacional. No total, estão previstos 15 mil reprodutores, de acordo com a convenção assinada com o Instituto de Investigação Agrícola para o Desenvolvimento.

Para garantir um acompanhamento rigoroso da utilização e do desempenho dos reprodutores, foi criado um dispositivo tripartido Instituto-projeto-ministério responsável, em estreita ligação com as profissões piscícolas regionais. Relatórios técnicos trimestrais, apoiados por um sistema digital de recolha de dados, permitem acompanhar os níveis de produção, a satisfação dos beneficiários e a eficácia das formações.

“Recebemos reprodutores certificados, com rendimentos muito bons. São raças estáveis, que crescem mais rapidamente e que nos evitam muitos problemas relacionados com a irregularidade e a falta de rastreabilidade das raças antigas. Isto vai transformar a nossa produção”, explica Hermine Kemedeu Tchuileu, beneficiária sediada em Douala, a capital económica.

A procura do mercado também está a sofrer uma transformação. Nos mercados populares e entre os restauradores, os peixes provenientes de reprodutores melhorados de clarias seduzem pela sua qualidade e sabor.

“A textura da carne permanece firme após a grelha, porque tem menos gordura do que as antigas variedades. O sabor atrai mais clientes e os meus rendimentos aumentaram significativamente”, explica Moukoudi Mbappé Dolie, vendedora de peixe grelhado em Douala.

A visita de campo aos mercados de Deïdo e Dakar, em Douala, permitiu constatar as condições precárias em que as comerciantes de peixe trabalhavam.

Isso levou à integração no projeto de um plano de reabilitação específica dos espaços de venda, nomeadamente a construção de infraestruturas adequadas, tais como balcões higiénicos, acesso a gelo e água corrente e a criação de zonas seguras.

“O projeto devolve-nos a esperança. Trabalhar com condições melhores não é um luxo, é uma necessidade. Balcões limpos e seguros vão ajudar-nos a conservar melhor o peixe e a vendê-lo com dignidade”, congratula-se Marthe Epoko, vendedora no mercado de Deïdo.

Para além das ações imediatas, a reabilitação em curso das estações piscícolas de Bamenda, Yaoundé e Foumban permitirá reforçar consideravelmente a oferta nacional de alevins de qualidade. Estes polos regionais tornar-se-ão centros de abastecimento estratégicos para centenas de piscicultores em todo o país.

O Projeto de Desenvolvimento das Cadeias de Valor da Pecuária e da Piscicultura não é, portanto, apenas um projeto de apoio pontual. Constitui um verdadeiro ecossistema de desenvolvimento local, ancorado numa lógica de resiliência, formação, inovação e inclusão. Insere-se plenamente na política nacional de transformação do setor rural.

“Vamos garantir um acompanhamento de proximidade às incubadoras beneficiárias. É essencial que a rastreabilidade, o desempenho dos reprodutores e a qualidade dos alevins produzidos sejam garantidos. Este projeto é estruturante para o futuro da nossa fileira aquícola”, sublinha Victor Viban Banah, delegado regional do Ministério da Pecuária, Pesca e Indústrias Animais para o Litoral.

Distribuído pelo Grupo APO para African Development Bank Group (AfDB).

Media files

Baixar .tipo

CEO da Fundação Merck nomeia a Primeira-Dama da Nigéria como Embaixadora do Programa “Mais do Que uma Mãe” para apoiar a educação de meninas e acabar com o estigma da infertilidade

Source: Africa Press Organisation – Portuguese –

Fundação Merck (www.Merck-Foundation.com), o braço filantrópico da Merck KGaA Alemanha sublinhou o seu compromisso com o desenvolvimento da capacidade de cuidados de saúde, apoio à educação das raparigas e combate ao estigma da infertilidade na Nigéria durante a sua reunião de alto nível com S.E. Senadora OLUREMI TINUBU, CON, Primeira-Dama da República Federativa da Nigéria. A conversa foi conduzida pelo Prof. Dr. Frank Stangenberg Haverkamp, Presidente do Conselho de Curadores da Fundação Merck e pela Senadora, Drª Rasha Kelej, CEO da Fundação Merck.

A Senadora Drª Rasha Kelej exprimiu, “Foi um privilégio manter encontro com a minha querida irmã S.E. Senadora OLUREMI TINUBU, CON, Primeira-Dama da República Federativa da Nigéria e nomeá-la oficialmente como Embaixadora do Programa “Mais do Que uma Mãe”. Durante a nossa reunião, discutimos o início da nossa parceria de longo prazo e destacamos o nosso compromisso com o desenvolvimento de capacidade na área da saúde e a transformação do cenário de atendimento aos pacientes, com a oferta de bolsas de estudo para médicos nigerianos locais em 42 especialidades críticas e carentes. Também discutimos a abordagem de questões sociais e de saúde críticas no País, incluindo o combate do estigma da infertilidade e o apoio à educação de meninas.

“É com grande prazer que partilho que, até hoje, 63 bolsas de estudo foram concedidas a médicos na Nigéria e reafirmo o nosso compromisso em aprimorar a prestação de serviços de saúde através da concessão de bolsas de estudo a médicos locais na Nigéria”, acrescentou a Drª Rasha Kelej.

S.E. Senadora OLUREMI TINUBU, CON, Primeira-Dama da República Federativa da Nigéria e Embaixadora do Programa “Mais do Que uma Mãe” exprimiu, é um prazer receber em audiência e manter encontro com o Presidente e a CEO da Fundação Merck no nosso País. Estou realmente feliz em saber sobre os seus programas impactantes e altamente benéficos, em particular o programa Educar Linda, que apoia a educação de meninas, e o programa de bolsas de estudo para aprimorar a capacidade de atendimento à saúde. É encorajador saber que a Fundação Merck concedeu 63 bolsas de estudo a nossos médicos locais em especialidades médicas críticas. Estou totalmente empenhada em expandir todos os seus programas para beneficiar a nossa população.

O Prof. Dr. Frank Stangenberg Haverkamp, Presidente do Conselho de Curadores da Fundação Merck partilhou, “Foi um grande prazer manter encontro com S.E., a Senadora OLUREMI TINUBU, CON, Primeira-Dama da República Federativa da Nigéria, e reforçar o nosso compromisso, partilhado com o avanço da capacidade de assistência à saúde na Nigéria e em toda a África.

O nosso objectivo é melhorar a saúde e o bem-estar geral das pessoas, fortalecendo a capacidade de assistência à saúde em África, na Ásia e noutros países em desenvolvimento. Estamos fortemente comprometidos em transformar o cenário de assistência ao paciente através do nosso programa de bolsas de estudo. Até hoje, já concedemos mais de 2282 bolsas de estudo para jovens médicos de 52 países em 44 especialidades críticas e carentes”.

A Fundação Merck concedeu 63 bolsas de estudo a médicos nigerianos, das quais 8 foram para Fertilidade, Embriologia, Medicina Sexual e Reprodutiva, Biotecnologia da Reprodução Humana Assistida e Embriologia e Saúde da Mulher.

Além disso, 38 bolsas foram concedidas para Diabetes, Medicina Cardiovascular Preventiva, Cardiologia, Endocrinologia e Obesidade e Controlo de Peso. Após a conclusão do curso, esses médicos poderão estabelecer clínicas da diabetes ou da hipertensão nos seus Centros de Saúde ou Hospitais, com o objectivo de ajudar a prevenir e controlar a doença nas suas próprias comunidades.

Além disso, 17 bolsas foram concedidas para outras especialidades críticas e carentes, como Investigação Oncológica, Psiquiatria Clínica, Dermatologia na Prática Clínica, Gestão da Dor, Medicina Respiratória, Cuidados com Idosos, Terapia Intensiva, Reumatologia e outras.

Além disso, como parte do programa ‘Educar Linda’, a Fundação Merck também patrocinou a educação de 20 estudantes nigerianas de alto desempenho, mas desfavorecidas.

A Fundação Merck também realizou três edições do Treinamento em Mídia da Saúde online para os jornalistas nigerianos, enfatizar o importante papel que a mídia desempenha na influência da sociedade, criando uma mudança cultural com o objectivo de abordar uma ampla gama de questões sociais e de saúde, como: Combate ao Estigma da Infertilidade, Apoio da Educação de Meninas, Empoderamento das Mulheres, Acabar com o Casamento Infantil, Acabar com a MGF e/ou Acabar com a VBG em todos os níveis; enfatizar a importância de Empoderar Meninas e Mulheres na Educação e compreender o impacto social e psicológico do estigma da infertilidade e de outras questões sociais, como VBG, Casamento Infantil, MGF, etc., sobre as mulheres, suas famílias e comunidades.

Além disso, conscientizar sobre a detecção precoce e a prevenção da Diabetes e da Hipertensão.

A Fundação Merck em parceria com a Primeira-Dama da Nigéria também lançou os seus 8 Prémios importantes da Fundação Merck do Jornalismo, da Canção, Moda, Cinema, e para estudantes e novos talentos com potencial nessas áreas.

“Convido os jovens talentos nigerianos a partilharem os seus trabalhos criativos e inspiradores connosco. Já celebramos muitos vencedores da Nigéria nos anos anteriores e estamos ansiosos para celebrar os vencedores deste ano também”, concluiu a Senadora Drª Kelej.

Informações sobre os Prémios:

  1. Prémio de Jornalismo Fundação Merck 2025 “Diabetes e Hipertensão”: Representantes da comunicação social são convidados a mostrar o seu trabalho através de mensagens fortes e influentes para promover um estilo de vida saudável e aumentar a conscientização sobre a prevenção e a detecção precoce da diabetes e da hipertensão.

Prazo final para submissão: 30 de outubro de 2025.

  1. Prémio de Moda Fundação Merck 2025 “Diabetes e Hipertensão”: Todos os estudantes e estilistas de moda africanos são convidados a criar e partilhar designs para transmitir mensagens fortes e influentes para promover um estilo de vida saudável e aumentar a conscientização sobre a prevenção e a detecção precoce de diabetes e hipertensão.

Prazo final para submissão: 30 de outubro de 2025.

  1. Prémio o Cinema Fundação Merck 2025 “Diabetes e Hipertensão”: Todos os cineastas africanos, estudantes de instituições de formação cinematográfica ou jovens talentos de África são convidados a criar e partilhar um FILME longo ou curto, seja drama, documentário ou docudrama para transmitir mensagens fortes e influentes para promover um estilo de vida saudável e aumentar a consciencialização sobre a prevenção e a detecção precoce da diabetes e da hipertensão. Prazo final para submissão: 30 de setembro de 2025.
  1. Prémio da Canção Fundação Merck 2025 “Diabetes e Hipertensão”: Todos os cantores e artistas musicais africanos são convidados a criar e partilhar uma MÚSICA com o objectivo de promover um estilo de vida saudável e aumentar a conscientização sobre a prevenção e a detecção precoce da diabetes e da hipertensão. Prazo final para submissão: 30 de setembro de 2025.
  1. Prémio de Jornalismo Fundação Merck “Diabetes & Hipertensão” 2025: Representantes da mídia são convidados a apresentar o seu trabalho através de mensagens fortes e influentes para promover um estilo de vida saudável e aumentar a conscientização sobre a prevenção e detecção precoce da diabetes e da hipertensão.
    Prazo final para submissão: 30 de outubro de 2025.  
  1. Prémio de Moda Fundação Merck “Diabetes & Hipertensão” 2025: Todos os estudantes e estilistas de moda são convidados a criar e partilhar designs para transmitir mensagens fortes e influentes para promover um estilo de vida saudável e aumentar a conscientização sobre a prevenção e detecção precoce da diabetes e da hipertensão.
    Prazo final para submissão: 30 de outubro de 2025.
  1. Prémio do Cinema Fundação Merck “Diabetes & Hipertensão” 2025: Todos os cineastas, estudantes de instituições de formação cinematográfica ou jovens talentos da África são convidados a criar e partilhar um FILME longo ou curto, seja drama, documentário ou docudrama para transmitir mensagens fortes e influentes para promover um estilo de vida saudável, aumentar a conscientização sobre a prevenção e detecção precoce da diabetes e da hipertensão.
    Prazo final para submissão: 30 de outubro de 2025.
  1. Prémio da Canção Fundação Merck “Diabetes & Hipertensão” 2025: Todos os cantores e artistas musicais estão convidados a criar e partilhar uma MÚSICA com o objectivo de promover um estilo de vida saudável e conscientizar sobre a prevenção e detecção precoce da diabetes e da hipertensão. Prazo final para submissão: 30 de outubro de 2025.

As inscrições para os prémios acima podem ser enviadas para nós em:

submit@merck-foundation.com

Para informações sobre os prémios, visite o nosso site:

www.Merck-Foundation.com

Distribuído pelo Grupo APO para Merck Foundation.

Contato:
Mehak Handa
Gerente do Programa de Conscientização Comunitária
Telefone: +91 9310087613 / +91 9319606669
Email: mehak.handa@external.merckgroup.com

Junte-se à conversa nas plataformas das nossas mídias sociais e deixe a sua voz ser ouvida:
Facebook: http://apo-opa.co/4lTBIEH
X: http://apo-opa.co/3VszrWm
YouTube: http://apo-opa.co/4lXLKVt
Instagram: http://apo-opa.co/3I62X15
Threads: http://apo-opa.co/3JNx0uR
Flickr: http://apo-opa.co/3HUyZ04
Website: www.Merck-Foundation.com
Baixar a Aplicação da Fundação Merck: https://apo-opa.co/4g2l1Wq

Sobre a Fundação Merck:
A Fundação Merck, criada em 2017, é o braço filantrópico da Merck KGaA Alemanha, tem como objectivo melhorar a saúde e o bem-estar das pessoas e aprimorar as suas vidas atravez da ciência e da tecnologia. Os nossos esforços estão focados principalmente na melhoria do acesso a soluções de saúde de qualidade e equitativas em comunidades carenciadas, no desenvolvimento da capacidade de saúde e na investigação científica, no empoderamento das raparigas na educação e no empoderamento de pessoas em STEM (Ciência, Tecnologia, Engenharia e Matemática) com foco especial em mulheres e jovens. Todos os comunicados de imprensa da Fundação Merck são distribuídos por e-mail ao mesmo tempo em que são disponibilizados no site da Fundação Merck. Visite www.Merck-Foundation.com para ler mais. Siga a mídia social da Fundação Merck: Facebook (http://apo-opa.co/4lTBIEH), X (http://apo-opa.co/3VszrWm), Instagram (http://apo-opa.co/3I62X15), YouTube (http://apo-opa.co/4lXLKVt), Threads (http://apo-opa.co/3JNx0uR) e Flickr (http://apo-opa.co/3HUyZ04).

A Fundação Merck está dedicada a melhorar os resultados sociais e de saúde para comunidades necessitadas. Embora colabore com vários parceiros, incluindo governos, para atingir os seus objectivos humanitários, a Fundação permanece estritamente neutra em questões políticas. Ela não se envolve ou apoia nenhuma actividade política, eleições ou regimes, concentrando-se exclusivamente na sua missão de elevar a humanidade e melhorar o bem-estar, mantendo uma postura estritamente apolítica em todos os seus esforços.

Media files

Baixar .tipo

Cameroon: Fish farming makes a difference in the fight to improve living standards

Source: APO

Along the coast and in south-western regions of Cameroon, fish ponds have become not only centres of production but also hubs of opportunity and economic transformation. A new dynamic is bringing hope to fish farmers, including young people and women, thanks to the Livestock and Fish Farming Value Chain Development Project (PD-CVEP in the French acronym), financed by the African Development Bank (AfDB) to the tune of 84 million euros and implemented by Cameroon’s Ministry of Livestock, Fisheries and Animal Industries.

This transformation has been driven by a strain of the African catfish (clarias), which has the advantages of rapid growth, low fat content, and low mortality. The strain was developed by Cameroon’s Agricultural Research Institute for Development. The fish are superior to earlier varieties in several ways: they reach a harvest weight of 350–500 grammes in just five to six months, compared to eight or nine months for earlier strains; the fry have a survival rate of 80 to 85%, compared to around 60% previously; and each female can produce 15,000 to 20,000 fry per cycle, with up to three cycles per year.

A total of 2,600 broodstock fish were delivered to 50 hatcheries selected for the pre-extension phase of the Project. The aim is to improve the genetic quality of the fish, strengthen the autonomy of fish farmers, and respond to food security challenges.

The pilot hatcheries have used the broodstock to produce and sell more than 115,000 fry since October 2024, mainly to be grown to full size. Results in the pre-extension phase have been very encouraging. Most of the hatcheries have reported satisfactory performance. Some of the broodstock, which were still immature when received, required a period of about three months for further growth, which was incorporated into the production schedule.

“The support given by the Project is encouraging us to go further. We have real motivation to continue what we’ve started. We thank all the partners who have made this progress possible. Today, I feel better equipped to make a profit from fish farming,” says Fanta Njifondjou Oumarou, a woman fish farmer in Limbé, a coastal town in north-western Cameroon.

The project goes far beyond the provision of broodstock. It is part of an integrated vision for the development of fish farming. A total of 280 fish farmers from different regions of Cameroon have received comprehensive training in all aspects of the value chain, from floating cage farming to reproduction, hatchery management, aquaculture feed, and business management. The aim is to strengthen the technical capacities of stakeholders, their economic resilience, and the quality of products offered on the local market.

The strategic objective of the Livestock and Fish Farming Value Chain Development Project is to increase annual national fish production by 10,000 tons by 2027, reducing dependence on imports and improving food security. To achieve this ambition, an AfDB mission in April 2025 recommended accelerating the supply of improved clarias and tilapia broodstock to enrich the gene pool. A total of 15,000 broodstock (12,000 clarias and 3,000 tilapia) are to be delivered under an agreement signed with the Agricultural Research Institute for Development.

A tripartite system involving the Institute, the Project, and the Ministry works closely with regional fish farming associations to ensure rigorous monitoring of the use and performance of broodstock. Quarterly technical reports, supported by a digital data collection system, enable monitoring of production levels, beneficiary satisfaction, and training effectiveness.

“We have received certified broodstock with very good yields. These are reliable strains that grow faster and avoid many of the problems associated with the irregularity and lack of traceability of the old strains. This will transform our production,” explains Hermine Kemedeu Tchuileu, a beneficiary based in Douala, Cameroon’s economic capital.

Market demand is also undergoing a transformation. Market traders and restaurants appreciate the improved quality and taste of the fish produced from the new clarias broodstock.
“The flesh stays firm after grilling because it contains less fat than older strains. The flavour appeals to customers and my income has increased significantly,” says Ms. Moukoudi Mbappé Dolie, who sells grilled fish in Douala.

A field visit to the Deïdo and Dakar markets in Douala highlighted the difficult working conditions of fishmongers in Cameroon. This led to the inclusion in the Project of an upgrading plan for sales facilities, including the installation of hygienic counters, access to ice and running water, and proper security.

“The project gives us hope. Working in better conditions isn’t a luxury – it’s a necessity. Clean and secure counters will help us to preserve the fish better and to sell with dignity,” says Marthe Epoko, a vendor at the Deïdo market.

In the longer term, ongoing improvements to fish farms in Bamenda, Yaoundé, and Foumban will significantly strengthen the national supply of quality fish fry. These regional hubs will become strategic supply centres for hundreds of fish farmers across the country.

As can be seen, the PD-CVEP is more than a one-off support project. It is a genuine local development ecosystem, rooted in resilience, training, innovation, and inclusion. It is fully in line with Cameroon’s national policy for rural transformation.

“We will provide close support to the beneficiary hatcheries. It is essential that traceability, broodstock performance, and the quality of the fry are guaranteed. This project is crucial for the future of our aquaculture sector,” emphasizes Victor Viban Banah, regional delegate of the Ministry of Livestock, Fisheries and Animal Industries for Cameroon’s coastal region.

Distributed by APO Group on behalf of African Development Bank Group (AfDB).

Media files

.

Merck Foundation Chief Executive Officer (CEO) appoints the Nigeria First Lady as their “More Than a Mother” Ambassador to Support Girl Education and Break Infertility Stigma

Source: APO

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany underscored their commitment to build healthcare capacity, support girl education and break infertility stigma in Nigeria during their high-level meeting with H.E. Senator OLUREMI TINUBU, CON, The First Lady of the Federal Republic of Nigeria. The discussion was led by Prof. Dr. Frank Stangenberg Haverkamp, Chairman of Merck Foundation BOT and Senator, Dr. Rasha Kelej, CEO of Merck Foundation.

Senator Dr. Rasha Kelej expressed, “It was a privilege to meet my dear sister H.E. Senator OLUREMI TINUBU, CON, The First Lady of the Federal Republic of Nigeria and officially appoint her to be the Ambassador of “Merck Foundation More Than a Mother”. During our meeting, we discussed the beginning of our long-term partnership and underscored our commitment towards building healthcare capacity and transforming patient care landscape by providing scholarships for local Nigerian doctors in 42 critical and underserved specialties. We also discussed about addressing critical social and health issues in the country including breaking the infertility stigma and supporting girl education.”

“It gives me great pleasure to share that till today, 63 scholarships have been provided for doctors in Nigeria and affirm our commitment towards enhancing healthcare delivery by providing scholarships for local doctors in Nigeria.” Dr Rasha Kelej added.

H.E. Senator OLUREMI TINUBU, CON, The First Lady of the Federal Republic of Nigeria and Ambassador of “Merck Foundation More Than a Mother” expressed, “It is a pleasure to welcome and meet the Chairman and CEO of Merck Foundation in our country. I am truly pleased to learn about their impactful and highly beneficial programs, particularly Educating Linda program to support girl education and scholarship program for advancing healthcare capacity. It is encouraging to know that Merck Foundation has provided 63 scholarships to our local doctors in critical medical specialties. I am fully committed to scaling up all their programs to benefit our people.”

Prof. Dr. Frank Stangenberg Haverkamp, Chairman of Merck Foundation BOT shared, “It was a great pleasure to meet H.E. Senator OLUREMI TINUBU, CON, The First Lady of the Federal Republic of Nigeria, and to reinforce our shared commitment to advancing healthcare capacity in Nigeria and across Africa.

Our aim is to improve the overall health and wellbeing of people by building healthcare capacity across Africa, Asia and other developing countries. We are strongly committed to transforming patientcare landscape through our scholarships program. Till today, we have provided more than 2282 scholarships for young doctors from 53 countries in 44 critical and underserved specialties.”

Merck Foundation has provided 63 scholarships for Nigerian doctors, out of which 8 scholarships have been provided for Fertility, Embryology, Sexual & Reproductive Medicine, Biotechnology of Human Assisted Reproduction and Embryology and Women’s Health.

Moreover, 38 scholarships have been provided for Diabetes, Preventative Cardiovascular Medicine, Cardiology, Endocrinology and Obesity & Weight Management. After completion of the course, these doctors will be able to establish diabetes or hypertension clinics in their Health Centre or Hospital with the aim to help prevent and manage the disease in their own communities.

Additionally, 17 scholarships have been provided for other critical and underserved specialties like Oncology Research, Clinical Psychiatry, Dermatology in Clinical Practice, Pain Management, Respiratory Medicine, Care of the Older Person, Critical Care, Rheumatology, and more.

Moreover, As a part of their ‘Educating Linda’ program, Merck Foundation has also sponsored the education of 20 high performing but underprivileged Nigerian schoolgirls.

Merck Foundation has also conducted three edition of Online Health Media Training for the Nigerian journalists, to emphasize on the important role that media plays to influence society to create a cultural shift with the aim to address wide range of social and health issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels; to underscore the importance of Empowering Girls and Women in Education and to understand the social and psychological impact of infertility stigma and other social issues like GBV, Child Marriage, FGM etc. over women and their families and communities.

Moreover, to raise awareness of early detection and prevention of Diabetes and Hypertension.

Merck Foundation in partnership with The First Lady of Nigeria has also launched their 8 important Merck Foundation Awards for Media, Musicians & Singers, Fashion Designers, Filmmakers, and students & new potential talents in these fields.

“I invite the young Nigerian talents to share their creative and inspiring work with us. We have celebrated many winners from Nigeria in the previous years and look forward to celebrating winners this year too,” concluded Senator Dr. Kelej.

Details of the Awards:

  1. Merck Foundation Media Recognition Awards “More Than a Mother” 2025: Media representatives and media students are invited to showcase their work to raise awareness about one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30th September 2025.
  1. Merck Foundation Fashion Awards “More Than a Mother” 2025: All Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to raise awareness about one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30th September 2025.
  1. Merck Foundation Film Awards “More Than a Mother” 2025: All Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to address one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30th September 2025.
  1. Merck Foundation Song Awards “More Than a Mother” 2025: All Singers and Musical Artists are invited to create and share a SONG with the aim to address one or more of the following social issues: Breaking Infertility Stigma and Women Empowerment. Submission deadline: 30th September 2025.
  1. Merck Foundation Media Recognition Awards “Diabetes & Hypertension” 2025: Media representatives are invited to showcase their work through strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.
    Submission deadline: 30th October 2025.
  1. Merck Foundation Fashion Awards “Diabetes & Hypertension” 2025: All Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.
    Submission deadline: 30th October 2025.
  1. Merck Foundation Film Awards “Diabetes & Hypertension” 2025: All Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to promote a healthy lifestyle, raise awareness about prevention and early detection of Diabetes and Hypertension.
    Submission deadline: 30th October 2025.
  1. Merck Foundation Song Awards “Diabetes & Hypertension” 2025: All Singers and Musical Artists are invited to create and share a SONG with the aim to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.
    Submission deadline: 30th October 2025.

Entries for the above awards can be submitted to us at: 

submit@merck-foundation.com

For information on the awards, please visit our website:

www.Merck-Foundation.com

Distributed by APO Group on behalf of Merck Foundation.

Contact:
Mehak Handa
Community Awareness Program Manager 
Phone: +91 9310087613/ +91 9319606669
Email: mehak.handa@external.merckgroup.com

Join the conversation on our social media platforms below and let your voice be heard:
Facebook: http://apo-opa.co/4lTBIEH
X: http://apo-opa.co/3VszrWm
YouTube: http://apo-opa.co/4lXLKVt
Instagram: http://apo-opa.co/3I62X15
Threads: http://apo-opa.co/3JNx0uR
Flickr: http://apo-opa.co/3HUyZ04
Website: www.Merck-Foundation.com
Download Merck Foundation App: https://apo-opa.co/4g2l1Wq

About Merck Foundation:
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare & scientific research capacity, empowering girls in education and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website.  Please visit www.Merck-Foundation.com to read more. Follow the social media of Merck Foundation: Facebook (http://apo-opa.co/4lTBIEH), X (http://apo-opa.co/3VszrWm), Instagram (http://apo-opa.co/3I62X15), YouTube (http://apo-opa.co/4lXLKVt), Threads (http://apo-opa.co/3JNx0uR) and Flickr (http://apo-opa.co/3HUyZ04).

The Merck Foundation is dedicated to improving social and health outcomes for communities in need. While it collaborates with various partners, including governments to achieve its humanitarian goals, the foundation remains strictly neutral in political matters. It does not engage in or support any political activities, elections, or regimes, focusing solely on its mission to elevate humanity and enhance well-being while maintaining a strict non-political stance in all of its endeavors.

Media files

.

Former Trinidad Energy Minister to Bring Gas Monetization, Local Content Expertise to African Energy Week (AEW 2025)

Source: APO

Eric Williams, former Minister of Energy and Energy Industries of Trinidad & Tobago, will join African Energy Week (AEW) 2025: Invest in African Energies in Cape Town to speak on gas monetization, local content frameworks and energy project structuring across Africa.

As President and Principal Consultant at Royal Triangle Energy Solutions, Williams has advised governments and private investors on strategies to maximize the economic and social impact of energy projects. His work spans key African markets, including Equatorial Guinea, Ghana and Mozambique, where he has provided guidance on LNG strategy, local workforce participation, and regulatory compliance. At the Congo Energy & Investment Forum earlier this year, Williams offered strategic input on local-participation frameworks under evolving regulatory regimes, highlighting his hands-on approach to aligning government and industry priorities.

Williams’ experience in Trinidad & Tobago – a country with a mature gas and LNG sector that has successfully balanced resource monetization with local economic development – provides valuable lessons for African markets. His expertise in designing policies that encourage domestic participation, attract private investment and foster sustainable growth offers a blueprint for African governments aiming to maximize the impact of their gas and energy resources.

“Eric Williams brings a rare combination of deep governmental experience and practical private sector insight. He understands the challenges of balancing resource development with local economic growth, and his perspective on aligning policy, regulation, and investment is invaluable. AEW 2025 attendees will benefit tremendously from his insights on how African nations can structure their energy sectors to be both profitable and inclusive,” said Ore Onagbesan, Program Director at AEW: Invest in African Energies.

Williams’ participation at AEW 2025 underscores the growing emphasis on sustainable, locally inclusive energy development in Africa. He will participate in high-level discussions on policy frameworks, project structuring, and public-private collaboration, helping stakeholders navigate complex regulatory landscapes while unlocking local economic benefits.

AEW – Africa’s premier energy gathering – will convene industry leaders, policymakers and investors to explore opportunities across the continent’s energy sector, from oil and gas to renewables and energy transition initiatives. Williams’ contribution promises to deepen understanding of how strategic advisory and policy alignment can accelerate Africa’s energy growth while fostering inclusive development.

Distributed by APO Group on behalf of African Energy Chamber.

About AEW: Invest in African Energies:
AEW: Invest in African Energies is the platform of choice for project operators, financiers, technology providers and government, and has emerged as the official place to sign deals in African energy. Visit www.AECWeek.com for more information about this exciting event.

Media files

.

How do bodies decompose? Cape Town forensic scientists are pushing frontiers of new detection methods

Source: The Conversation – Africa – By Victoria Gibbon, Professor in Biological Anthropology, Division of Clinical Anatomy and Biological Anthropology, University of Cape Town

Cape Town has consistently been one of the metropolitan regions in South Africa with the highest murder rates. It has more than double the national average, and is currently ranked second overall and 16th worldwide. Many victims are discovered only after their bodies have decomposed, burned, or been exposed to the elements. That makes identification difficult and delays justice.

Each year, more than 3,500 unnatural deaths, including murders and accidents, are handled by the city’s Observatory Forensic Pathology Institute. Around 9% remain unidentified. That’s hundreds of families left without answers. We asked Victoria Gibbon and colleagues about their work in forensic taphonomy.

What is the role of forensic taphonomists?

In death, we all decompose in the same general way. But understanding the nuances, especially those introduced by unnatural deaths, requires forensic taphonomy – the science of understanding how bodies break down. Every decomposition process is unique. It is shaped by everything around us: what we’re wearing, how we’re buried and what animals and insects might find us first.

Forensic taphonomists study all these variables and more, specialising in the recovery and analysis of human remains in the context of their environment. They play a vital role in death investigations involving unidentified persons, which requires specialised expertise in the human body and environment. There is a close working relationship with police and pathologists who hold the responsibility for identification and circumstances of death.

Imagine: a body is uncovered amid the sand and scrub of Cape Town’s coastline. By the time it’s found, the remains are in an advanced state of decomposition – identity unclear, the timeline murky. Understanding decomposition helps to determine how long someone has been dead, which can support identification, narrow down missing persons lists, or confirm (or contradict) witness accounts. It’s essential, delicate and some could say, grim work.


Read more: Clothed pig carcasses are revealing the secrets of mummification – South African study provides insights for forensic scientists


Forensic taphonomists’ expertise lies in understanding how bodies decompose under different conditions and how that process can reveal time-since-death, potential trauma, and ultimately, identity. Forensic taphonomists answer questions like: Who was this person? How long have they been there? And what happened to them? Their work sits at the intersection of science, justice and innovation. Because in the end, forensic science is about justice, not just science.

One of the main challenges in forensic taphonomy is that many of the global standards were developed in countries with very different climates and ecological systems. So, they are not representative of South Africa. Cape Town’s internationally unique microclimates, soil types and scavenger populations don’t align neatly with existing models.

To produce locally relevant data, researchers need to observe how decomposition actually happens in these settings. In South Africa, the legislation does not allow forensic taphonomists to study the decomposition of human bodies donated to medical science for research, as happens elsewhere in the world. Therefore they most frequently study the decomposition of adult domestic pigs as internationally accepted models for human decomposition. Pigs have numerous biological similarities to humans that are important for decomposition.

Initial decomposition studies in the Western Cape more than a decade ago began by examining unclothed bodies to establish baseline data. But as it turns out, that’s not what most cases look like. In reality, most deceased persons are clothed, and usually discovered alone. This mismatch prompted a shift.

What have you done differently in your research?

More realistic, single-body, clothed studies were needed. That meant smaller sample sizes, longer timelines, and greater data accuracy. But it leads to findings that are actually applicable in local forensic work.

We innovated, creating a world-first automated data collection machine to tackle the challenge of consistency and cost-effective, reliable long-term monitoring. It tracks decomposition in real-time, continuously and remotely. As bodies lose mass (due to water evaporation, insect activity, or tissue breakdown), the machine logs the weight changes, providing high-resolution data on the progression of decomposition. This removes the subjectivity of human observation. It allows researchers to collect standardised information across multiple cases and environments, simultaneously. It is solar-powered and transmits data remotely via cell phone networks, meaning it can be deployed anywhere we need to establish data for.

Our system has tracked in detail how tissues dry out beneath the skin. This can help reconstruct the time since death by linking drying patterns to environmental conditions and weather.

In addition to weighing decomposing bodies, our system provides continuous power to two motion-activated infrared trail cameras.


Read more: How scavengers can help forensic scientists identify human corpses


One camera trap is positioned directly above the body; the other is alongside the body. Together, these cameras record photos and videos of the decomposition process, giving us detailed insight into the activities of the animals that come to eat and otherwise interact with the decomposing body.

Cape grey mongoose scavenging pig body during summer 2022 experimental deployment. K Adams and Cape4Taph UCT research group

This machine offers precision, reliability and adaptability. It transforms how decomposition can be studied.

What’s next?

This technological innovation isn’t just a local solution. The team aims to provide a means by which researchers from different countries can share results that are directly comparable. These will form the basis for a global taphonomic data network: a collaborative platform for researchers to gain insights into decomposition as it plays out across geographies, environments and case types.

The hope is that this network will allow forensic anthropologists to adapt decomposition estimates to local contexts while contributing to an international evidence base.

Collectively, our research innovations may help produce more accurate case outcomes, that are admissible in court, and capable of providing justice for victims. Assistance with case resolution means restoring the identities of those who might otherwise have been lost to justice and history.

– How do bodies decompose? Cape Town forensic scientists are pushing frontiers of new detection methods
– https://theconversation.com/how-do-bodies-decompose-cape-town-forensic-scientists-are-pushing-frontiers-of-new-detection-methods-262832

We decoded the oldest genetic data from an Egyptian, a man buried around 4,500 years ago – what it told us

Source: The Conversation – Africa – By Adeline Morez Jacobs, Postdoctoral researcher, University of Padova (Italy); visiting lecturer, Liverpool John Moores University (UK), University of Padua

A group of scientists has sequenced the genome of a man who was buried in Egypt around 4,500 years ago. The study offers rare insight into the genetic ancestry of early Egyptians and reveals links to both ancient north Africa and Mesopotamia, which includes modern day Iraq and parts of Syria, Turkey and Iran.

Egypt’s heat and terrain made it difficult for such studies to be conducted but lead researcher Adeline Morez Jacobs and team made a breakthrough. We spoke to her about the challenges of sequencing ancient remains, the scientific advances that made this discovery possible, and why this genome could reshape how we understand Egypt’s early dynastic history.


What is genome sequencing? How does it work in your world?

Genome sequencing is the process of reading an organism’s entire genetic code. In humans, that’s about 3 billion chemical “letters” (A, C, T and G). The technology was first developed in the late 1970s, and by 2003 scientists had completed the first full human genome. But applying it to ancient remains came much later and has been far more difficult.

DNA breaks down over time. Heat, humidity and chemical reactions damage it, and ancient bones and teeth are filled with DNA from soil microbes rather than from the individual we want to study. In early attempts during the 1980s, scientists hoped mummified remains might still hold usable DNA. But the available sequencing methods weren’t suited to the tiny, fragmented molecules left after centuries or millennia.

To sequence DNA, scientists first need to make lots of copies of it, so there’s enough to read. Originally, this meant putting DNA into bacteria and waiting for the colonies to grow. It took days, demanded careful upkeep and yielded inconsistent results. Two breakthroughs changed this.

In the early 1990s, PCR (polymerase chain reaction) allowed millions of DNA copies to be made in hours, and by the mid-2000s, new sequencing machines could read thousands of fragments in parallel. These advances not only sped up the process but also made it more reliable, enabling even highly degraded DNA to be sequenced.

Since then, researchers have reconstructed the genomes of extinct human relatives like Neanderthals, and more than 10,000 ancient people who lived over the past 45,000 years. But the work is still challenging – success rates are low for very old remains, and tropical climates destroy DNA quickly.

What’s exceptional about the sequencing you did on these remains?

What made our study unusual is that we were able to sequence a surprisingly well-preserved genome from a region where ancient DNA rarely survives.

When we analysed the sample, we found that about 4%-5% of all DNA fragments came from the person himself (the rest came from bacteria and other organisms that colonised the remains after burial). The quantity of DNA of interest (here, human) is usually between 40% and 90% when working with living organisms. That 4%-5% might sound tiny, but in this part of the world, it’s a relatively high proportion, and enough to recover meaningful genetic information.

We think the individual’s unusual burial may have helped. He was placed inside a ceramic vessel within a rock-cut tomb, which could have shielded him from heat, moisture and other damaging elements for thousands of years.

Rock cut tombs at Nuwayrat enclosing the pottery vessel containing the pottery coffin burial. Image courtesy of the Garstang Museum of Archaeology, University of Liverpool. As in Morez Jacobs, A. et al. (2025). Nature

To make the most of this rare preservation, we filtered out the very shortest fragments, which are too damaged to be useful. The sequencing machines could then focus on higher-quality pieces. Thanks to advanced facilities at the Francis Crick Institute, we were able to read the DNA over and over, generating about eight billion sequences in total. This gave us enough data to reconstruct the genome of what we call the Nuwayrat individual, making him the oldest genome from Egypt to date.

Does this open new frontiers?

We did not develop entirely new techniques for this study but we combined some of the most effective methods currently available into a single optimised pipeline. This is what palaeogeneticists (scientists who study the DNA of ancient organisms) often do: we adapt and refine existing methods to push the limits of what can be recovered from fragile remains.

That’s why this result matters. It shows that, with the right combination of methods, we can sometimes retrieve genomes even from places where DNA usually doesn’t survive well, like Egypt.

Egypt is also a treasure trove for archaeology, with remains that could answer major questions about human history, migration and cultural change.

Our success suggests that other ancient Egyptian remains might still hold genetic secrets, opening the door to discoveries we couldn’t have imagined just a decade ago.

What was your biggest takeaway from the sequencing?

The most exciting result was uncovering this man’s genetic ancestry. By comparing his DNA to ancient genomes from Africa, western Asia and Europe, we found that about 80% of his ancestry was shared with earlier north African populations, suggesting shared roots within the earlier local population. The remaining 20% was more similar to groups from the eastern Fertile Crescent, particularly Neolithic Mesopotamia (present-day Iraq).

This might sound expected, but until now we had no direct genetic data from an Old Kingdom (2686–2125 BCE) Egyptian individual. The results support earlier studies of skeletal features from this period, which suggested close links to predynastic populations, but the genome gives a far more precise and conclusive picture.

This genetic profile fits with archaeological evidence of long-standing connections between Egypt and the eastern Fertile Crescent, dating back at least 10,000 years with the spread of farming, domesticated animals and new crops into Egypt. Both regions also developed some of the world’s first writing systems, hieroglyphs in Egypt and cuneiform in Mesopotamia. Our finding adds genetic evidence to the picture, suggesting that along with goods and ideas, people themselves were moving between these regions.

Of course, one person can’t represent the full diversity of the ancient Egyptian society, which was likely complex and cosmopolitan, but this successful sequencing opens the door for future studies, building a richer and more nuanced picture of the people who lived there over thousands of years.

– We decoded the oldest genetic data from an Egyptian, a man buried around 4,500 years ago – what it told us
– https://theconversation.com/we-decoded-the-oldest-genetic-data-from-an-egyptian-a-man-buried-around-4-500-years-ago-what-it-told-us-262061

Genetic tests for cancer can give uncertain results: new science is making the picture clearer to guide treatment

Source: The Conversation – Africa – By Claudia Christowitz, Postdoctoral Research Fellow, Stellenbosch University

Cancer treatment is becoming more personalised. By considering a patient’s unique genetic and molecular profile, along with their lifestyle and environmental factors, doctors can make more accurate treatment decisions. This approach, known as personalised or precision medicine, has been increasingly used in South Africa and has expanded to other African countries in recent decades. It requires doctors to rely more on genetic tests to guide decisions. But these tests don’t always give clear answers. Functional genomics may offer a way to improve the interpretation of unclear genetic test results. We spoke to physiological scientist Claudia Christowitz about it.


Is cancer a genetic disease and what is personalised medicine?

Cancer is fundamentally a genetic disease. It arises when changes in a person’s DNA (referred to as variants or mutations) disrupt normal cell functions such as cell growth and division. It eventually leads to tumour formation. These changes can be inherited from families or acquired during a person’s lifetime. This can be due to lifestyle and environmental risk factors such as smoking, ultraviolet radiation and infectious agents, among others.

Over the past few decades, we’ve entered the era of personalised medicine. As a result, the role of genetics in cancer treatment has become more prominent. Personalised medicine involves tailoring cancer treatment to each patient’s unique characteristics.

For example, even if two people are diagnosed with the same type and stage of cancer, their treatment outcomes may differ. This is because factors such as their genetic and molecular make-up, overall health status, age, body composition, lifestyle habits, and use of other medication can all influence how well a treatment works for them.

How have advances in genetic testing helped in treating cancer?

Advances in DNA sequencing technologies have made it possible to detect genetic variants more quickly and accurately. The tests can look for just a few genes linked to certain medical conditions, or they can describe the entire genome of an individual, or just the protein-coding regions of the genome (the exome).

DNA sequencing has revolutionised cancer care. Doctors can use it to improve prevention in people who are at risk of cancer, detect cancer early, and select the most appropriate treatment.

Africa’s first high-throughput Genomics Centre was launched in 2019 by the South African Medical Research Council. Cancer patients can now undergo whole exome sequencing and whole genome sequencing locally for around R10,000 (about US$566) to R20,000 (about US$1,132). This is sometimes covered by medical insurance. These services are also available at research facilities like the Centre for Proteomic and Genomic Research or the Centre for Epidemiological Research and Innovation at Stellenbosch University.

These facilities strengthen the capacity to sequence, analyse and store human genomes, particularly for the diverse gene pool in Africa. But routine genome sequencing, especially in the public health sector, remains limited due to high costs, limited awareness and the need for trained personnel.

What are the shortcomings of genetic testing?

Genetic testing doesn’t provide all the answers. Unfortunately, not all genetic results are clear-cut. In many cases, patients receive results showing changes in their DNA that cannot be confidently classified as either harmful (pathogenic variants or mutations) or harmless (benign variants). These unclassified variants are known as variants of uncertain significance. The uncertainty often leaves both patients and their oncologists (cancer doctors) unsure of the way forward.

With the advancement of sequencing technologies, rare or novel variants are more frequently detected. But without a clear understanding of whether the variant affects gene function, clinicians are often forced to wait – sometimes for years – until more information emerges.

When patients undergo genetic testing – often as part of a hereditary cancer screening or in response to early-onset or familial cancers – the hope is to find a variant that clearly explains their condition. But sequencing may yield variants of uncertain significance, raising questions about its usefulness in patient care and whether the tests are worth the cost.

What is functional genomics and how can it make genetic test results clearer?

Functional genomics is a growing field that could transform how we interpret these unresolved genetic results and make it possible to improve clinical care for cancer patients.

Functional genomics goes beyond simply reading the DNA code. It investigates how genetic variants behave in biological systems. By examining how a variant alters gene expression, protein function, cell behaviour, or response to treatments, scientists can determine whether it is likely to be benign or pathogenic.

This information is crucial for making timely medical decisions. Importantly, cells derived from patients can be used to mimic real biological conditions more accurately. By using cells carrying such a variant and comparing them to cells without the variant, scientists can determine whether the variant is influencing the response of cells to certain treatments or not.

In short: genetic testing is like reading the “instruction manual” of a cell. Functional genomics is like testing the effects of changes to these instructions.

My study, using patient-derived cells, investigated the effects of a rare TP53 variant that was identified for the first time in germline (inherited) DNA through whole exome sequencing in a South African family with multiple cancers. I found that this variant made cells resistant to the chemotherapy drug doxorubicin. Instead of undergoing cell death as expected, the cells went into a kind of “sleep mode” called senescence, where damaged cells stop dividing.

Although this prevents the growth of damaged cells, senescent cells can release signals that may inflame and harm nearby healthy cells. The variant also reduced how well immune cells can move, which may affect their ability to go to cancer cells and attack them. This study, supervised by Prof Anna-Mart Engelbrecht, Prof Maritha Kotze, and Dr Daniel Olivier from Stellenbosch University, highlighted how functional genomics can unravel the impact of a variant of uncertain significance, which may guide medical decisions.

In a world where personalised medicine is rapidly evolving, functional genomics represents a critical step forward, offering more clarity, better care, and renewed hope to those facing cancer.

– Genetic tests for cancer can give uncertain results: new science is making the picture clearer to guide treatment
– https://theconversation.com/genetic-tests-for-cancer-can-give-uncertain-results-new-science-is-making-the-picture-clearer-to-guide-treatment-262545

Afreximbank affiche de solides résultats pour le premier semestre 2025, conformément aux attentes

Source: Africa Press Organisation – French


La Banque Africaine d’Import-Export (« Afreximbank ou le Groupe ») (www.Afreximbank.com) a publié ses états financiers consolidés, pour le semestre clos le 30 juin 2025 (Premier semestre 2025).

Dans un contexte de tensions géopolitiques accrues, de pressions inflationnistes persistantes, de volatilité des devises et de conditions de financement mondiales plus strictes, le groupe Afreximbank a une fois de plus réalisé des résultats satisfaisants pour le premier semestre (au S1’2025). Cette performance, qui a dépassé celle de la période comparative 2024, reflète un revenu net plus élevé, une situation de liquidité solide et un renforcement des réserves de capitaux, ce qui permet au Groupe de mieux s’acquitter de son mandat dans l’ensemble de ses Etats membres d’Afrique et de la Communauté des Caraïbes.

Le revenu brut a augmenté de 2,04 % sur la période comparative, atteignant 1,6 milliard de dollars US au premier semestre 2025. Le revenu net d’intérêt s’élèvent à 835,9 millions de dollars US, soit une augmentation de 1,17 % par rapport à la période précédente. Cette croissance modeste a été réalisée malgré la baisse des taux de référence mondiaux, reflétant largement la gestion efficace des coûts de financement du Groupe. Les revenus bruts d’honoraires et de commissions provenant des activités non financées, y compris l’émission de garanties, les lettres de crédit (passifs éventuels) et la fourniture de services consultatifs, se sont élevés à 61,9 millions de dollars US.

Nonobstant une hausse de 21% des charges d’exploitation, le Groupe a maintenu un ratio coûts/produits très favorable à 19%, globalement en conformité avec les seuils historiques et bien en dessous du plafond stratégique de 30%. L’augmentation des dépenses a été principalement due à la mise en œuvre d’initiatives stratégiques et au recrutement de personnel supplémentaire pour soutenir les activités croissantes du Groupe et aux pressions inflationnistes.

Le bilan et les éléments éventuels d’Afreximbank ont clôturé le premier semestre 2025 à 42,5 milliards de dollars US, soit une croissance de 6,0 % par rapport à la position au 31 décembre 2025 (exercice 2024). Les prêts et avances (le portefeuille) s’élevaient à 27,7 milliards de dollars US (Exercice 2024 : 29,0 milliards de dollars US). Cette diminution du portefeuille de prêts et d’avances s’explique par les remboursements anticipés effectués par certains emprunteurs souverains, qui ont bénéficié de la hausse des prix des produits de base et de l’amélioration des positions en devises. Avec des Prêts non performants (PNP) à 2,48 % pour le premier semestre 2025 (EF 2024 : 2,33 %), la qualité du portefeuille est restée saine et bien dans les limites prudentes. Le ratio de liquidité de la Banque s’est amélioré de manière significative pour clôturer la période à 22 % (EF 2024 :13 %), les liquidités et équivalents de trésorerie détenus s’élevant à 8,3 milliards de dollars américains (EF 2024 :4,6 milliards de dollars US).  

Les fonds des actionnaires ont atteint 7,3 milliards de dollars US (AF 2024 : 7,2 milliards de dollars US). Ils sont surtout tirés par des bénéfices générés en interne de 412,7 millions de dollars US et des entrées de capitaux frais dans le cadre de l’augmentation générale du capital II en cours. Un dividende total de 350 millions de dollars US au titre de l’exercice 2024 a été affecté après approbation des actionnaires lors de la dernière assemblée générale tenue en juin 2025.

Afreximbank est également ravie d’accueillir le Dr George Elombi, qui a été approuvé à l’unanimité par les actionnaires lors de notre Assemblée générale annuelle de juin 2025 en tant que quatrième président d’Afreximbank et président du conseil d’administration de la Banque, succédant au Professeur Benedict Oramah qui achève son second mandat en octobre 2025. Cette nomination fait suite à la brillante carrière de Dr Elombi au sein de la Banque, qui s’étend sur près de trois décennies, où il occupe actuellement le poste de vice-président exécutif chargé de la gouvernance, des services juridiques et ministériels.

M. Denys Denya, premier vice-président exécutif d’Afreximbank, a déclaré :

« Le Groupe Afreximbank a enregistré une performance satisfaisante au premier semestre 2025, faisant preuve d’agilité et de résilience malgré un environnement difficile. Le Groupe a continué à soutenir les États membres en leur proposant des solutions financières novatrices, en s’appuyant sur une solide base de capitaux, un accès aux marchés des capitaux, comme en témoignent la saine situation de liquidité et l’excellente connaissance des marchés africains et caribéens par la Direction. L’engagement inébranlable de la direction dans le cadre de son mandat de développement, le développement de l’Afrique et de la région des Caraïbes grâce au commerce, à l’industrialisation et à l’intégration économique, demeurent la pierre angulaire du succès du Groupe.

Les fondamentaux du Groupe restent solides, et la Direction continue de se concentrer sur la création de valeur à long terme pour toutes les parties prenantes, tout en préservant la souveraineté financière de l’Afrique ».

Les résultats phares du Groupe sont présentés ci-après : 

Indicateurs de performance financière

 1er semestre 2025

1er semestre 2024

Revenu brut (millions de dollars US)

1 588,2

1  556,5

Revenu net (en millions de dollars US)

412,7

407,7

Rendement des fonds propres moyens (ROAE)

11 %

13 %

Rendement de l’actif moyen (ROAA)

2,22 %

2,52 %

Ratio coût/revenus

19 %

17 %

Indicateurs de performance financière

1er semestre 2025

EF 2024

Total des actifs du bilan et imprévus (en milliards de dollars US)

42,5

40,1

Actif total (en milliards de dollars US)

37,7

35,3

Total des passifs (en milliards de dollars US)

30,4

28,1

Fonds propres (en milliards de dollars US)

7,3

7,2

Valeur de l’actif net par action

70 140 $ US

69 695 $ US

Ratio des Prêts non performants (PNP)

2,48 %

2,33 %

Liquidités/Total des actifs

22 %

13 %

Ratio d’adéquation des fonds propres (Bâle II)

24 %

24 %

Distribué par APO Group pour Afreximbank.

Contact Presse :
Vincent Musumba
Responsable de la communication et de la gestion événementielle (Relations presse)
Courriel : press@afreximbank.com

Suivez-nous sur :
X : https://apo-opa.co/4nawEwM 
Facebook : https://apo-opa.co/45IjX6E 
LinkedIn : https://apo-opa.co/465P9Md 
Instagram : https://apo-opa.co/4mORt1g

À propos d’Afreximbank :
La Banque Africaine d’Import-Export (la « Banque ») est une institution multilatérale de financement du commerce, créée en octobre 1993. La Banque a commencé ses activités en septembre 1994. Afreximbank a son siège social au Caire, en Égypte. Le mandat de la Banque est de promouvoir, financer et faciliter le commerce intra et extra-africain tout en opérant commercialement.

La Banque détient une participation majoritaire de 100 % dans FEDA Holdings, FEDA Investments Management et FEDA Capital (collectivement appelées entités FEDA), qui ont été établies en 2021. Le FEDA a été initié par Afreximbank et établi par un traité entre les états participants africains pour faciliter les flux d’investissements directs étrangers dans les secteurs commercial et négociable de l’Afrique et pour combler le déficit de financement par actions sur le continent. La Banque a constitué Afreximbank Insurance Management Company (AfrexInsure) en 2021. Cette société vise à aider l’Afrique à conserver, sur le continent, une part importante des primes d’assurance souscrites liées au commerce. En outre, la Banque a également constitué deux entités : African Medical Centre of Excellence Limited (AMCE), dont les principales activités consistent à fournir des installations médicales et sanitaires de classe mondiale, et African Quality assurance Centre Limited (AQAC), une société créée pour garantir que les produits fabriqués en Afrique répondent aux normes internationales et aux réglementations techniques applicables. L’AQAC offre des services d’essais, d’inspection et de certification, y compris la formation en évaluation de la conformité. En outre, la Banque détient une participation majoritaire dans l’ Adjustment Fund Corporation Limited (AFCFTA) et CANEX Creations Incorporated (CANEX).

Afreximbank est notée A par GCR International Scale, Baa2 par Moody’s, AAA par China Chengxin International Credit Rating Co., Ltd (CCXI), A- par Japan Credit Rating Agency (JCR) et BBB par Fitch.

Pour de plus amples informations, veuillez visiter www.Afreximbank.com

DÉCLARATIONS PROSPECTIVES :
Le Groupe de la Banque africaine d’Import-Export (Afreximbank) procède de temps à autre à des déclarations prospectives écrites et/ou orales, comme indiqué dans cette publication et dans d’autres communications. De même, les dirigeants de la Banque peuvent faire des déclarations prospectives, soit par écrit, soit lors de conversations verbales avec des investisseurs, des analystes, les médias et d’autres membres de la communauté financière. Les déclarations concernant les stratégies, les objectifs et les priorités de la Banque, ainsi que les performances financières prévues pour la période, constituent des déclarations prospectives. Elles sont souvent exprimées par des termes tels que « devrait », « serait », « pourrait », « s’attendre à », « anticiper », « estimer », « projeter », « avoir l’intention de » et « croire ».

De par leur nature, ces déclarations obligent la Banque à formuler des hypothèses exposées à des risques et incertitudes, notamment en lien avec l’environnement financier, économique, réglementaire et social dans lequel la Banque exerce ses activités. Certains de ces risques échappent au contrôle de la Banque et peuvent entraîner des résultats sensiblement différents de ceux qui pourraient être déduits des déclarations prospectives. Les facteurs de risque susceptibles d’entraîner de telles divergences comprennent notamment les décisions réglementaires, le risque de crédit, de marché (y compris actions, matières premières, devises et taux d’intérêt), de liquidité, opérationnel, de réputation, d’assurance, stratégique, juridique, environnemental, ainsi que d’autres risques connus ou inconnus. En conséquence, lors de toute prise de décision concernant la Banque, il est recommandé aux lecteurs de procéder à une évaluation complémentaire et de ne pas accorder une confiance excessive aux déclarations prospectives de celle-ci.

Toute déclaration prospective figurant dans la présente présentation reflète uniquement les opinions de la direction à la date des présentes. Elles sont communiquées dans le but d’aider les investisseurs et les analystes de la Banque à comprendre la situation financière de la Banque, ses stratégies, objectifs, priorités ainsi que sa performance financière anticipée pour la période en cours et, à ce titre, peuvent ne pas convenir à d’autres fins. La Banque ne s’engage pas à mettre à jour une déclaration prospective, qu’elle soit écrite ou verbale, qui pourrait être faite de temps à autre par elle ou en son nom, sauf dans les cas exigés par les dispositions ou obligations réglementaires applicables.

Equatorial Guinea to Launch EG Ronda 2026 Licensing Round at African Energy Week (AEW) 2025 Amid Surge in Upstream Investment

Source: APO


.

Equatorial Guinea will launch its highly anticipated EG Ronda 2026 licensing round at this year’s African Energy Week (AEW): Invest in African Energies, taking place from September 29 to October 3 in Cape Town. The licensing round takes place Monday 29 September and forms part of the country’s broader strategy to revitalize its upstream sector, attract new investment and unlock exploration and production opportunities offshore. The licensing round will be officially unveiled during a high-level session – Equatorial Guinea’s New Exploration Drive – at AEW: Invest in African Energies 2025, led by Antonio Oburu Ondo Minister of Hydrocarbons and Mining Development, Equatorial Guinea. During this session, detailed geological data will be presented, offering investors insight into the structure, stratigraphy and prospectivity of Equatorial Guinea’s offshore basins. 

In preparation for EG Ronda 2026, the Ministry of Hydrocarbons and Mining Development has partnered with U.K.-based Searcher Seismic on a $60 million program to acquire and reprocess 2D and 3D seismic data across uncharted acreage. The initiative aims to provide prospective investors with high-quality datasets, de-risking exploration and highlight frontier potential across Equatorial Guinea’s offshore basins. By offering robust technical data packages, the government seeks to boost competitiveness, restore investor confidence and strengthen long-term energy security. 

AEW: Invest in African Energies is the platform of choice for project operators, financiers, technology providers and government, and has emerged as the official place to sign deals in African energy. Visit www.AECWeek.com for more information about this exciting event. 

The licensing round comes at a pivotal moment for Equatorial Guinea, with a series of recent developments underscoring renewed international interest in the country’s oil and gas sector. 

In June 2025, energy major ConocoPhillips transported its inaugural LNG cargo from the Punta Europa facility, advancing the country’s flagship Gas Mega Hub initiative. Following its 2024 acquisition of Marathon Oil, ConocoPhillips now holds interests in the Alba Unit and Block D, securing long-term participation in both gas and liquid development. This company is also undergoing an infill drilling campaign in Alba Block, Independent operator Trident Energy continues to deliver strong results from Block G – home to the Ceiba and Okume fields – where it holds a 40.375% operated stake. In late 2024, the company brought online its first infill well and is enhancing subsea integrity through a digital twin solution developed with Canadian technology firm Enaimco. Upstream oil company Kosmos Energy, a partner in Block G with a 40% participating interest, recently completed an exploration drilling campaign and is reprocessing seismic data with advanced technology to high-grade future opportunities. Both companies are focused on sustaining production while de-risking future development, reinforcing Equatorial Guinea’s status as a hub for upstream investment. 

Oil and gas company Panoro Energy has also expanded its footprint with the signing of a production sharing contract (PSC) for Block EG-23, in partnership with Equatorial Guinea’s national oil company (NOC) GEPetrol. The shallow-water block covers 600km2 and holds an estimated 104 million barrels of oil and condensate and 215 billion cubic feet of gas in contingent resources. Panoro Energy is initially undertaking subsurface studies before moving into exploration drilling, highlighting the untapped potential of Equatorial Guinea’s offshore acreage. 

Meanwhile, hydrocarbon exploration company Vaalco Energy is advancing development of Block P, which holds the Venus discovery and over 20 million barrels of recoverable oil. With a final investment decision expected soon, the project is targeting first oil in 2026 and peak output in 2028. The entry of Vaalco Energy to Equatorial Guinea marks another milestone in the country’s drive to restore production growth. 

Multinational energy corporation Chevron entered Equatorial Guinea by acquiring Noble Energy. This major recently signed two new PSCs for Blocks EG-06 and EG-11, representing a $2 billion investment with GEPetrol. Located near the Zafiro field, the blocks include deepwater acreage and a prior discovery at Avestruz-1. The agreements underscore the renewed confidence of international majors in Equatorial Guinea’s resource base and fiscal environment, as the country positions itself for a new era of exploration-led growth. 

As the country’s NOC, GEPetrol is driving the transformation of Equatorial Guinea’s upstream sector through strategic partnerships, deepwater field redevelopments and targeted operational advancements. By optimizing legacy assets, accelerating exploration and implementing technical innovations, the company is aiming at boosting production, strengthening operational efficiency and reinforcing its position as a premier national operator. Equatorial Guinea’s offshore geology is characterized by deepwater and shallow-water sedimentary basins rich in hydrocarbons. The region features a mix of Tertiary and Cretaceous reservoirs, with proven structural traps and complex stratigraphic plays. Significant potential exists in both proven fields and underexplored frontier acreage, particularly in the deepwater areas, where high-quality reservoirs and source rocks create exploration targets for oil and gas development. 

On the regulatory side, Equatorial Guinea is focused on being highly competitive on a global scale.  Essential regimes have just gone or are going under a revision for optimization. The oil and gas companies were very instrumental to the recent reform of the Tax Regime, as well as the reform of the Labor Regime. The reform of the Petroleum Regime is said to be active by the end of the year 2025. 

“EG Ronda 2026 represents a major step in unlocking Equatorial Guinea’s offshore and onshore potential. It will attract leading investors, drive exploration and stimulate sustainable growth. We are committed to offering world-class fiscal and regulatory terms to support this development” states Minister Ondo. 

“Against this backdrop of heightened activity, EG Ronda 2026 will serve as the official platform to unlock the next wave of investment and exploration success in Equatorial Guinea. The licensing round offers new acreage opportunities to explore proven and innovative plays in modest water depths, with world-class fiscal packages and increasingly attractive terms. By offering improved and competitive fiscal frameworks alongside high-quality exploration potential, EG Ronda 2026 will launch the next era of exploration success when Equatorial Guinea will become, again, a global exploration and commercial hotspot for the industry.” 

 Click here (https://apo-opa.co/4nb9GWi) for your exclusive invitation to EG Ronda 2026.  

Distributed by APO Group on behalf of African Energy Chamber.